CRISPR Therapeutics AG

US$50.07As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRSPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 10.60%
Div yield —
ROE (25.60%)
Biotechnology
Beta (5Y) 1.90
PE TTM —
TSR TTM (21.75%)
Mkt cap US$4.857B
ROIC (322.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$64
28.54%
72.63%
Hold 7|0|9|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.72
0.81
0.82
0.83
16.46%
30.01%
29.45%
18.51%
Revenue$M
364.3
380.3
392.1
396.7
(1.49%)
2.22%
6.99%
6.94%
Peers (US$4.857B)
Cap (US$)
PE
7.324B
40.17x
2.414B
—
1.343B
—
Capital
TTM
5Y
10Y
Leveragex
0.962
0.200
0.188
EBIT/Intx
4.292
0.252
0.286
Own earn%
56.20
(180.77)
(109.10)
Sh yield%
34.57
48.00
44.81
Owners
Insiders/Inst%
3.30
29.60
Short interest%
3.04
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
8